Researchers are exploring the use of nanomedicines to treat tuberculosis, with various approaches being investigated, including inhalable nanomedicine and long-acting injectable drug delivery systems. Nanotechnology is also being applied to enhance tuberculosis vaccines and to develop targeted treatments for specific forms of the disease, such as female genital tuberculosis. The use of nanocarriers, including lipid-based drug delivery systems, is being studied as a potential means of improving tuberculosis treatment outcomes.